InvestorsHub Logo

stockless

01/30/15 10:31 PM

#27518 RE: stockless #27515

To finish talking to the hand I think they did fail to mention in there previous PR that they had previous debt to pay off to stay solvent. Knowing no one would be interested in investing. But in there defense they know they have something here in this patent, and like I said before, time doesn't go by without other people moving us closer to FDA approval.

surfkast

01/31/15 10:00 AM

#27529 RE: stockless #27515

They have been stating that they needed money for trialing to be able to submit for FDA approval. None of their financials show any funds ever going for trialing. EVER. Only for toxic debt. That is why the shares went from 156 million to possibly over TWO BILLION in the past year!


Convertible Loan Note debt has been applied for, providing a claim on 330 million reserved Common Stock shares at par value

Total shares outstanding: Common shares 1,184,894,145 09/30/2014

Convertible Loan Note debt has been applied for, providing a claim on 330 million reserved Common Stock shares at par value

Plus 117,500,000 ISSUED TO Blackbridge Capital, LLC

BASED ON THE ABOVE, MINIMUM O/S SHOULD BE 1,632,394,145 A/O 12/8/2014